Inicio > Ámbito regulatorio

Ámbito regulatorio

28/02/2011

Registration trials for specific immunotherapy in Europe: advanced guidance from the new European Medical Agency guideline

0

Registration trials for specific immunotherapy in Europe: advanced guidance from the new European Medical Agency guideline
V. Gödicke and F. Hundt. Allergy Volume 65, Issue 12, pages 1499–1505, December 2010

feb 28th, 2011. En: Ámbito regulatorio #

Regulatory environment for allergen-specific immunotherapy

0

vacuna de alergia 1Regulatory environment for allergen-specific immunotherapy
S. Kaul, S. May, D. Lüttkopf and S. Vieths. Allergy Vol. 66 Issue 3. Published online: 3 FEB 2011

feb 28th, 2011. En: Ámbito regulatorio #

The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens

0

The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: A Global Allergy and Asthma European Network (GA2LEN) article
P. J. Bousquet, M.A. Calderón, P.Demoly, D. Larenas, G. Passalacqua, C. Bachert, J. Brozek, G.W. Canonica, T. Casale, J. Fonseca, R. Dahl, S.R. Durham, H. Merk, M. Worm, U. Wahn, T. Zuberbier, H.J. Schünemann, J. Bousquet. Journal of Allergy and Clinical Immunology. Volume 127, Issue 1 , Pages 49-56.e11, January 2011.

feb 28th, 2011. En: Ámbito regulatorio #

Regulatory aspects of specific immunotherapy in Europe

0

Regulatory aspects of specific immunotherapy in Europe
Kaul S; Englert L; May S; Vieths S. Current Opinion in Allergy & Clinical Immunology: December 2010 – Volume 10 – Issue 6 – p 594–602

feb 28th, 2011. En: Ámbito regulatorio #